Evaluation of Intravesical LP08 in Patients With Interstitial Cystitis/Painful Bladder Syndrome

NCT01393223 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Interstitial Cystitis

Interventions

DRUG: LP-08 80mg
DRUG: Normal saline
DRUG: LP-08 20mg

Sponsor

Lipella Pharmaceuticals, Inc.

Collaborators

[object Object]